ADA and severe combined immunodeficiency: Examples include, Strimvelis, the first stem-cell based gene therapy, an autologous CD34+ HSC product with wildtype adenosine deaminase (ADA) sequence introduced by a ɣ-retroviral vector for the treatment of ADA-severe combined immunodeficiency [31].